Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT02341911. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
ClinicalTrials.gov study NCT02989584. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases
ClinicalTrials.gov study NCT05371223. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01964534. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00789633. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer
ClinicalTrials.gov study NCT00639925. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas
ClinicalTrials.gov study NCT03779464. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT03502343. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer
ClinicalTrials.gov study NCT05074589. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00114179. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
ClinicalTrials.gov study NCT00073983. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00703365. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT01496534. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma
ClinicalTrials.gov study NCT01192633. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or Nivolumab
ClinicalTrials.gov study NCT02628574. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients
ClinicalTrials.gov study NCT02767557. IPD Sharing: YES. Countries: 2. Publications: 1.
Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT01909830. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)
ClinicalTrials.gov study NCT00779584. IPD Sharing: YES. Countries: 0. Publications: 1.
Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum
ClinicalTrials.gov study NCT01426126. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00070486. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.